Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › MA › BOSTON › MASSACHUSETTS EYE AND EAR INFIRMARY

MASSACHUSETTS EYE AND EAR INFIRMARY

NPI: 1639101751 · BOSTON, MA 02114 · Eyewear Supplier · NPI assigned 07/07/2006

$68.24M
Total Medicaid Paid
862,670
Total Claims
789,352
Beneficiaries
208
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialCURRAN, EARL (DIRECTOR FINANCE)
NPI Enumeration Date07/07/2006

Related Entities

Other providers sharing the same authorized official: CURRAN, EARL

ProviderCityStateTotal Paid
MASSACHUSETTS EYE AND EAR INFIRMARY BOSTON MA $449K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 116,829 $7.81M
2019 114,057 $9.06M
2020 87,030 $7.59M
2021 127,481 $10.55M
2022 143,349 $11.79M
2023 143,449 $10.65M
2024 130,475 $10.80M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
J9035 Injection, bevacizumab, 10 mg 4,942 4,677 $9.29M
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 57,377 53,367 $6.84M
J0178 Injection, aflibercept, 1 mg 7,483 7,102 $4.26M
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis 6,849 6,444 $4.21M
67028 Intravitreal injection of a pharmacologic agent 23,587 22,234 $3.12M
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 28,042 26,078 $3.10M
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia 2,129 2,102 $2.70M
92014 Ophthalmological services: medical examination and evaluation, comprehensive, established patient 45,635 44,199 $2.53M
42820 Tonsillectomy and adenoidectomy; younger than age 12 1,445 1,408 $2.22M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 90,858 78,171 $1.86M
31575 10,483 9,897 $1.74M
99283 Emergency department visit for the evaluation and management, moderate severity 17,406 16,455 $1.66M
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 13,906 10,241 $1.47M
31231 8,318 7,959 $1.42M
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 10,109 9,839 $1.20M
92557 18,624 18,005 $1.17M
J0585 Injection, onabotulinumtoxina, 1 unit 2,507 1,938 $1.11M
V5261 Hearing aid, digital, binaural, bte 1,278 1,217 $952K
99282 Emergency department visit for the evaluation and management, low to moderate severity 8,939 8,580 $868K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 7,926 7,689 $861K
31237 1,028 909 $832K
66982 1,443 1,370 $790K
92004 Ophthalmological services: medical examination and evaluation, comprehensive, new patient 10,778 10,504 $740K
V5160 Dispensing fee, binaural 1,446 1,408 $724K
99284 Emergency department visit for the evaluation and management, high severity 7,100 6,766 $712K
92567 20,343 19,799 $653K
31579 1,184 1,138 $552K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 2,892 2,793 $552K
64612 1,773 1,709 $540K
67228 798 736 $495K
92134 51,281 47,924 $478K
J2778 Injection, ranibizumab, 0.1 mg 1,028 969 $448K
42830 240 239 $434K
76512 6,628 5,678 $426K
99215 Prolong outpt/office vis 3,547 3,339 $370K
70491 3,316 3,186 $358K
68761 2,396 2,273 $341K
70543 1,387 1,334 $315K
92235 2,161 2,083 $252K
70486 2,638 2,558 $250K
92083 25,318 24,457 $236K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 1,927 1,829 $233K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 2,456 1,588 $222K
99281 Emergency department visit for the evaluation and management, self-limited or minor 2,710 2,530 $218K
C9257 Injection, bevacizumab, 0.25 mg 6,137 5,776 $193K
30520 221 214 $186K
70480 2,043 1,946 $182K
92012 Ophthalmological services: medical examination and evaluation, intermediate, established patient 3,180 3,031 $181K
92020 5,870 5,681 $172K
92579 4,630 4,514 $167K
69210 5,479 5,233 $166K
92133 23,302 22,663 $155K
92250 12,378 11,566 $153K
74230 1,224 1,192 $141K
92025 5,594 5,436 $136K
92504 5,183 4,855 $132K
30140 54 54 $118K
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 1,219 1,147 $115K
76536 1,594 1,532 $112K
92555 1,605 1,567 $110K
V5266 Battery for use in hearing device 2,913 2,861 $104K
88305 Level IV - Surgical pathology, gross and microscopic examination 4,549 3,478 $95K
V5264 Ear mold/insert, not disposable, any type 1,250 1,173 $91K
92587 657 641 $90K
92593 2,848 2,016 $85K
99205 Prolong outpt/office vis 766 746 $75K
67113 41 39 $74K
V5020 Conformity evaluation 1,679 1,139 $73K
92582 2,311 2,259 $63K
66821 200 194 $62K
J0171 Injection, adrenalin, epinephrine, 0.1 mg 11,991 10,829 $62K
92585 227 211 $59K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 24,936 18,998 $57K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 1,739 1,214 $50K
92285 5,386 5,136 $49K
76514 3,830 3,715 $47K
92595 1,331 860 $39K
92524 449 442 $38K
87070 4,368 3,993 $31K
92136 6,023 5,816 $31K
67108 12 12 $31K
J2704 Injection, propofol, 10 mg 15,853 13,502 $30K
92226 3,549 3,351 $27K
J3300 Injection, triamcinolone acetonide, preservative free, 1 mg 466 424 $27K
J2250 Injection, midazolam hydrochloride, per 1 mg 22,269 19,744 $27K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 5,208 4,651 $26K
V5011 Fitting/orientation/checking of hearing aid 311 185 $26K
J2405 Injection, ondansetron hydrochloride, per 1 mg 16,259 14,217 $26K
J3473 Injection, hyaluronidase, recombinant, 1 usp unit 648 602 $26K
G0378 Hospital observation service, per hour 621 329 $25K
92537 249 237 $25K
92591 501 490 $21K
J7999 Compounded drug, not otherwise classified 3,315 2,610 $21K
65426 12 12 $20K
92060 1,372 1,223 $20K
66761 34 30 $18K
71260 Computed tomography, thorax, diagnostic; with contrast material 975 937 $18K
92201 2,549 2,468 $17K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 17,248 15,031 $16K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 268 253 $13K
J3010 Injection, fentanyl citrate, 0.1 mg 9,881 8,899 $13K
69220 98 91 $13K
87102 1,455 1,337 $13K
92592 736 478 $13K
88300 1,772 1,741 $13K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 247 157 $12K
80048 Basic metabolic panel (calcium, ionized) 2,637 2,287 $10K
92604 416 381 $10K
J7050 Infusion, normal saline solution, 250 cc 890 603 $10K
J7120 Ringers lactate infusion, up to 1000 cc 4,577 4,212 $10K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 4,202 3,965 $9K
92540 357 344 $9K
A9575 Injection, gadoterate meglumine, 0.1 ml 4,153 3,985 $9K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 75 69 $9K
86480 285 273 $9K
J0690 Injection, cefazolin sodium, 500 mg 9,715 8,868 $9K
87081 803 754 $9K
92202 892 862 $8K
87205 2,847 2,605 $8K
66710 12 12 $7K
92225 1,088 1,006 $7K
V5014 Repair/modification of a hearing aid 295 289 $7K
92652 104 104 $6K
10005 15 15 $5K
J0131 Injection, acetaminophen, not otherwise specified,10 mg 174 137 $5K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 255 241 $5K
J1170 Injection, hydromorphone, up to 4 mg 4,711 3,913 $4K
92594 174 122 $4K
87077 712 679 $4K
J0330 Injection, succinylcholine chloride, up to 20 mg 4,417 4,125 $4K
V2632 Posterior chamber intraocular lens 4,789 4,520 $4K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 25 25 $4K
76516 174 157 $4K
87186 596 563 $4K
V5241 Dispensing fee, monaural hearing aid, any type 14 13 $3K
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 1,356 1,289 $3K
92590 23 23 $3K
86140 1,133 1,057 $3K
92081 487 474 $3K
S0020 Injection, bupivicaine hydrochloride, 30 ml 149 146 $3K
J2270 Injection, morphine sulfate, up to 10 mg 3,964 3,566 $3K
J0697 Injection, sterile cefuroxime sodium, per 750 mg 995 926 $2K
82164 315 299 $2K
86617 261 248 $2K
85652 1,651 1,537 $2K
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 1,455 1,404 $2K
87075 377 358 $2K
J0173 Injection, epinephrine (belcher), not therapeutically equivalent to j0171, 0.1 mg 1,847 1,738 $2K
92511 12 12 $2K
88304 291 229 $1K
92597 33 26 $1K
92546 110 106 $1K
86780 160 153 $1K
85549 126 118 $1K
86039 253 239 $1K
J1097 Phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml 40 37 $1K
L8699 Prosthetic implant, not otherwise specified 281 270 $1K
86592 436 416 $1K
92015 Determination of refractive state 2,327 2,112 $1K
ATP08 142 119 $1K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 45 26 $968.29
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 650 566 $830.53
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 27 24 $820.96
92626 12 12 $648.89
65222 14 13 $605.25
86481 14 12 $529.14
92553 13 13 $484.80
84443 Thyroid stimulating hormone (TSH) 38 37 $363.45
36415 Collection of venous blood by venipuncture 1,008 882 $341.59
85027 96 88 $327.75
V5010 Assessment for hearing aid 1,071 924 $322.50
V2630 Anterior chamber intraocular lens 1,049 985 $300.10
87206 100 94 $289.16
71250 44 44 $261.88
88342 40 39 $169.14
67820 69 63 $151.39
87285 13 12 $120.34
Q3014 Telehealth originating site facility fee 112 105 $107.61
82962 790 683 $102.82
88313 40 40 $93.23
80053 Comprehensive metabolic panel 92 84 $88.40
A4217 Sterile water/saline, 500 ml 42 40 $78.69
85610 27 26 $77.14
96375 Therapeutic injection; each additional sequential IV push 14 12 $69.96
A4263 Permanent, long term, non-dissolvable lacrimal duct implant, each 28 27 $68.85
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 677 555 $66.22
J2370 Injection, phenylephrine hcl, up to 1 ml 384 370 $60.50
81025 13 12 $57.24
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 21 12 $51.74
V2785 Processing, preserving and transporting corneal tissue 26 25 $36.46
J1885 Injection, ketorolac tromethamine, per 15 mg 70 64 $27.02
82565 13 13 $5.29
J1171 Injection, hydromorphone, 0.1 mg 78 50 $1.60
J0688 Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg 575 536 $0.00
80076 14 13 $0.00
J2004 Injection, lidocaine hcl with epinephrine, 1 mg 16 16 $0.00
J1596 Injection, glycopyrrolate, 0.1 mg 45 45 $0.00
J3260 Injection, tobramycin sulfate, up to 80 mg 20 15 $0.00
C9447 Injection, phenylephrine and ketorolac, 4 ml vial 12 12 $0.00
J9999 Not otherwise classified, antineoplastic drugs 41 39 $0.00
L8509 Tracheo-esophageal voice prosthesis, inserted by a licensed health care provider, any type 15 12 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 22 21 $0.00
A4262 Temporary, absorbable lacrimal duct implant, each 475 466 $0.00
J1630 Injection, haloperidol, up to 5 mg 41 38 $0.00
G0268 Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing 219 219 $0.00
00142 13 13 $0.00
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 12 12 $0.00
92082 16 13 $0.00